Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
USD 29.95
Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.

Contact Information

Av. Cesar Vallejo 565, Lince
Lima; Lima; Map
Tel: +51 1 221
Fax: +51 1422

Full name: Farmindustria S.A.

Status: Non-Listed
Legal Form: Public Limited Company
Operational Status: Operational
EMISid: 2399377
Incorporation Date: 01-Mar-95

Main Activities

Main Activities: Pharmaceutical and Medicine Manufacturing

Main Products

Chemical, pharmaceutical, nutritional, botanical, dietary supplements and cosmetics, spirits and other alcoholic beverages.


Company Description

Farmindustria SA, was founded on March 1995. It is a company that is specifically dedicated to the manufacture of pharmaceutical products, private label and licensed, in addition to providing tolling services. On the other hand, is integrated with Pharmalab, who represents the leading pharmaceutical group of Peruvian capital of the country and the second laboratory in the ranking of multinational laboratories. This merger took place on January 2006, absorbing all the operations and assets of Pharmalab, a…


Basic Information

Total Employees:
Outstanding Shares:
: ()
Financial Auditors:

EMIS Benchmark Score

View all parameters in Benchmark Score


2016: Imports USD 43,234.00 Thousands
Import connections ('000)
United Kingdom (43.16 USD)
Iceland (2.74 USD)
Netherlands (6.19 USD)
Austria (558.64 USD) (1.29 %)
Hong Kong (5.67 USD)
Malaysia (54.88 USD)
Puerto Rico
Japan (72.2 USD)
China (6273.11 USD) (14.51 %)
Sweden (632.72 USD) (1.47 %)
Switzerland (56.58 USD)
Italy (1010.57 USD) (2.34 %)
Vietnam (50.4 USD)
Czech Republic (45.06 USD)
United States (1420.28 USD) (3.28 %)
Spain (768.88 USD) (1.77 %)
France (31.14 USD)
Ireland (6.88 USD)
Belgium (18.5 USD)
Taiwan (12.3 USD)
North Korea (1170.41 USD) (2.71 %)
South Korea (1170.41 USD) (2.71 %)
Norway (1.59 USD)
Russia (12.2 USD)
Canada (7.81 USD)
Germany (148.76 USD)
Colombia (4947.39 USD) (11.44 %)
Argentina (2756.51 USD) (6.38 %)
India (9960.72 USD) (23.04 %)
Mexico (400.75 USD)
Brazil (415.18 USD)
Thailand (132.76 USD)
Israel (5.07 USD)
Chile (12114.86 USD) (28.02 %)
New Zealand (86.9 USD)
2016: Exports USD 2,580.64 Thousands
Export connections ('000)
Costa Rica (191.19 USD) (7.41 %)
Guatemala (14.05 USD)
China (12.7 USD)
Venezuela (541.72 USD) (20.99 %)
Paraguay (630.26 USD) (24.42 %)
India (93.28 USD) (3.61 %)
Italy (16.13 USD)
Brazil (4.25 USD)
Vietnam (59.24 USD) (2.30 %)
United States (6.5 USD)
Spain (18.58 USD)
Chile (519.35 USD) (20.12 %)
Dominican Republic (11.42 USD)
Bolivia (461.87 USD) (17.90 %)

Key Executives

General Manager

Ownership Details

Farmaceutica Mont Blanc S.l. (Spain)

Key Stats

Select Items to chart them. 2014 Y
Net sales revenue
Total operating revenue
Operating profit (EBIT)
Net Profit (Loss) for the Period
Total assets 396,901
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Individual
Source: Superintendencia del Mercado de Valores, EMIS Company Database.


Competitors - Peru


EMIS DealWatch Deals

DealMonitor Deal Intents

for 29.95 USD
Payment methods include:
USD 29.95
Most recent financial data: 2014
Payment methods include:
The full PDF report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest